# | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
---|
Trump confirmed his support for recreational cannabis in Florida. and sparked a reaction in the cannabis stock market on Monday.
RBC Capital analyst Brian Abrahams reiterates Corbus Pharmaceuticals (NASDAQ:CRBP) with a Outperform and maintains $82 price...